Drug discontinuation: Adalimumab-adaz Injection (HYRIMOZ)
FDA lists 5 presentations as To Be Discontinued. Companies: Sandoz Inc..
- Published by source
- 2026-01-13
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Sandoz Inc.
- Products
- Adalimumab-adaz Injection HYRIMOZ
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Equivalent Sandoz format is available.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-01-13
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #946 | new | 2026-10-22 | f6f27b627384…61d04b | 0c06e22bb976…b4a005 |
Chain head: #1076 8ad5adc30b9b…88ce20